Subcutaneous Tarlatamab Shows Safety and Early Activity in Small Cell Lung Cancer
A phase 1b study presented at the IASLC 2026 World Conference on Lung Cancer found that subcutaneous tarlatamab was well ...
Tag: cytokine release syndrome
Longer Gaps Between Tarlatamab Doses Show Promise in Small Cell Lung Cancer
The randomized Phase 2 DeLLphi-309 study found that extended-interval tarlatamab dosing every three or four weeks produced efficacy, safety and ...
Engineered T Cell Receptors Push Into Solid Tumors as 2026 ASCO Data Offer Hope and Caveats
A critical review of eight studies from the 2026 ASCO Annual Meeting shows TCR-engineered T-cell therapy produced no treatment-related deaths ...
Single-Cell Insights into Pediatric EBV-Linked HLH Biomarkers
In a groundbreaking advancement poised to revolutionize pediatric immunology, a team of researchers has unveiled novel biomarkers associated with Epstein-Barr ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!